Page last updated: 2024-09-05

sorafenib and melatonin

sorafenib has been researched along with melatonin in 4 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(melatonin)
Trials
(melatonin)
Recent Studies (post-2010) (melatonin)
6,5207305,25123,2681,4519,627

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)melatonin (IC50)
MyeloperoxidaseHomo sapiens (human)3
Ribosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)3.3323
Metabotropic glutamate receptor 1Rattus norvegicus (Norway rat)0.0004
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.0005
Melatonin receptor type 1AHomo sapiens (human)0.0025
Melatonin receptor type 1BHomo sapiens (human)0.0035

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baulies, A; Fernández, A; Fernández-Checa, JC; Garcia-Ruiz, C; González-Gallego, J; Mauriz, JL; Méndez-Blanco, C; Ordóñez, R; Prieto-Domínguez, N1
Gao, C; Herr, I; Hoffmann, K; Lin, S; Petrulionis, M; Schemmer, P1
Fang, Z; Han, B; Hong, SS; Jung, KH; Kang, YW; Kim, SJ; Lee, JE; Lim, JH; Park, JH; Rumman, M; Yan, HH1
Fan, L; Liu, J; Lu, Q; Sun, G; Wang, H; Wang, Y; Wei, W; Zhou, B1

Other Studies

4 other study(ies) available for sorafenib and melatonin

ArticleYear
Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.
    Journal of pineal research, 2016, Volume: 61, Issue:3

    Topics: Apoptosis; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Melatonin; Mitophagy; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Reactive Oxygen Species; Sorafenib

2016
Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma.
    Journal of pineal research, 2017, Volume: 62, Issue:3

    Topics: Anthracenes; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Melatonin; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Signal Transduction; Sorafenib

2017
Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 47, Issue:5

    Topics: Cell Line, Tumor; Drug Synergism; Humans; Melatonin; Neoplasm Proteins; Niacinamide; Pancreatic Neoplasms; Phenylurea Compounds; Receptor, Platelet-Derived Growth Factor alpha; Receptors, Melatonin; Signal Transduction; Sorafenib; STAT3 Transcription Factor

2018
Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway.
    International journal of biological sciences, 2019, Volume: 15, Issue:9

    Topics: Activating Transcription Factor 4; Autophagy; Beclin-1; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum Stress; Flow Cytometry; Fluorescent Antibody Technique; Hep G2 Cells; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Liver Neoplasms; Melatonin; Microscopy, Electron, Transmission; Signal Transduction; Sorafenib; Tissue Array Analysis

2019